You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
先健科技(01302.HK)擬斥資1.5億元戰略入股劍虎醫療 核心產品三維標測平臺已獲批上市
格隆匯 06-09 08:09

格隆匯6月9日丨先健科技(01302.HK)發佈公告,2025年6月6日,集團透過其全資附屬公司先健科技(深圳)有限公司(“先健深圳”)訂立一系列協議,內容有關擬投資於劍虎醫療科技(蘇州)有限公司(“劍虎醫療”)。先健深圳已同意以現金方式投資於劍虎醫療,合共人民幣1.5億元。該投資將根據投資協議所載若幹里程碑事件的達成情況分階段進行,包括劍虎醫療創始人與核心團隊訂立令先健深圳滿意的僱傭合同、保密協議及不競爭協議,以及劍虎醫療取得若幹特定產品的中國國家藥品監督管理局(“國家藥監局”)註冊證書。

該投資的部分將用於增加劍虎醫療的註冊資本,餘下金額將計入資本儲備。完成該投資的所有階段後,先健深圳將擁有劍虎醫療30%的股權,其中22.22%將於第一階段完成後立即獲得。預期該投資不會導致劍虎醫療成爲公司的附屬公司。

就該投資而言,先健深圳與劍虎醫療已訂立戰略合作協議,以共同促進創新心臟介入影像平臺產品的研究、開發及商業化。訂約雙方亦將探索聯合產品/技術開發、建立銷售平臺及其他形式的業務合作,以充分發揮各自的優勢和資源。集團將擁有劍虎醫療電生理相關產品的獨家優先合作權及海外獨家經銷權,包括但不限於三維標測設備、環形標測導管、高密標測導管、壓力大頭導管、射頻儀、脈衝消融儀、環形脈衝導管及其他產品。

劍虎醫療於2021年2月註冊成立,是一家集自主研發、設計、生產、銷售於一體的高端醫療器械創新型企業。劍虎醫療擁有強大的研發團隊,致力於通過自主創新,打造集心臟電生理三維標測、脈衝電場和射頻消融能量及各類導管耗材的一體化解決方案的平臺型公司。於2025年5月,劍虎醫療自主研發的StarTrek®三維標測平臺已獲國家藥監局的正式註冊批準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account